nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adeno-associated viral vector integration: implications for long-term efficacy and safety
|
Batty, Paul |
|
|
22 |
11 |
p. 2945-2960 |
artikel |
2 |
A new track for KDELivery of designer cargo by platelets
|
Kong, Yvonne X. |
|
|
22 |
11 |
p. 3007-3009 |
artikel |
3 |
Annoucements
|
|
|
|
22 |
11 |
p. 3331 |
artikel |
4 |
Atomistic characterization of β2-glycoprotein I domain V interaction with anionic membranes
|
Hasdemir, Hale S. |
|
|
22 |
11 |
p. 3277-3289 |
artikel |
5 |
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study
|
Kraler, Simon |
|
|
22 |
11 |
p. 3125-3136 |
artikel |
6 |
Brain-derived gangliosides prime human platelet aggregation and induce platelet-leukocyte aggregate formation
|
Noro, Fabrizia |
|
|
22 |
11 |
p. 3221-3234 |
artikel |
7 |
Coagulation protease–induced extracellular vesicles: their potential effects on coagulation and inflammation
|
Das, Kaushik |
|
|
22 |
11 |
p. 2976-2990 |
artikel |
8 |
Corrigendum to ‘COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry’ [Journal of Thrombosis and Haemostasis Volume 22, Issue 1, January 2024, Pages 61-75]
|
Sharathkumar, Anjali |
|
|
22 |
11 |
p. 3330 |
artikel |
9 |
CpG oligonucleotides induce acute murine thrombocytopenia dependent on toll-like receptor 9 and spleen tyrosine kinase pathways
|
Johansson, Karl |
|
|
22 |
11 |
p. 3266-3276 |
artikel |
10 |
Development of A structured integrated post-Pulmonary Embolism care model: The Attend-PE model
|
Højen, Anette Arbjerg |
|
|
22 |
11 |
p. 3137-3147 |
artikel |
11 |
Elevated lipopolysaccharide level is largely driven by time since symptom onset in acute ischemic stroke: the impact on clinical outcomes
|
Błaż, Michał |
|
|
22 |
11 |
p. 3161-3171 |
artikel |
12 |
Endothelial protein disulfide isomerase A1 enhances membrane stiffness and platelet-endothelium interaction in hyperglycemia via SLC3A2 and LAMC1
|
Gaspar, Renato S. |
|
|
22 |
11 |
p. 3305-3321 |
artikel |
13 |
Epidemiology, natural history, diagnosis, and management of ovarian vein thrombosis: a scoping review
|
Monnet, Margaux |
|
|
22 |
11 |
p. 2991-3003 |
artikel |
14 |
Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitors
|
Chen, Yingyu |
|
|
22 |
11 |
p. 3035-3047 |
artikel |
15 |
Evaluating the safety and effectiveness of direct oral anticoagulants compared with warfarin in very elderly patients with atrial fibrillation with and without low bodyweight
|
Patil, Tanvi |
|
|
22 |
11 |
p. 3107-3124 |
artikel |
16 |
Fibrinolysis is impaired in patients with primary immune thrombocytopenia
|
Schramm, Theresa |
|
|
22 |
11 |
p. 3209-3220 |
artikel |
17 |
Gene therapy for people with hemophilia B: a proposed care delivery model in Italy
|
Castaman, Giancarlo |
|
|
22 |
11 |
p. 3084-3096 |
artikel |
18 |
Hepatocyte-independent PAR1-biased signaling controls liver pathology in experimental obesity
|
Cline, Holly |
|
|
22 |
11 |
p. 3191-3198 |
artikel |
19 |
Hereditary antithrombin deficiency pilot project registry from the American Thrombosis and Hemostasis Network
|
DeSancho, Maria T. |
|
|
22 |
11 |
p. 3183-3190 |
artikel |
20 |
Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms
|
Bourrienne, Marie-Charlotte |
|
|
22 |
11 |
p. 3199-3208 |
artikel |
21 |
Issue Information
|
|
|
|
22 |
11 |
p. e1-e5 |
artikel |
22 |
Novel GPIb-independent platelet aggregation induced by botrocetin: implications for diagnosis and antithrombotic therapy
|
Shen, Chuanbin |
|
|
22 |
11 |
p. 3249-3265 |
artikel |
23 |
Production of physiological amounts of hemostatic proteins by human donor livers during ex situ long-term normothermic machine perfusion for up to 7 days
|
Lascaris, Bianca |
|
|
22 |
11 |
p. 3097-3106 |
artikel |
24 |
Rapid and ordered cleavage of prothrombin by Hopsarin D in the absence of phospholipid membranes
|
Üstok, Fatma Işık |
|
|
22 |
11 |
p. 3070-3083 |
artikel |
25 |
Rapid diagnosis of coagulopathies from vitamin K deficiency in a consecutive case cohort evaluated by comparative assessment of factor II by 1-stage assays with prothrombin time vs Ecarin reagents
|
Bourguignon, Alex |
|
|
22 |
11 |
p. 3059-3069 |
artikel |
26 |
Recognizing the 11th Year of World Thrombosis Day: A Call to Action for Health Care Professionals with a Focus on Women and Thrombosis
|
Castellucci, Lana A. |
|
|
22 |
11 |
p. 2943-2944 |
artikel |
27 |
Sensitivity and specificity of strategies to identify patients with hemostasis abnormalities leading to an increased risk of bleeding before scheduled intervention: the Hemorisk study
|
Ajzenberg, Nadine |
|
|
22 |
11 |
p. 3048-3058 |
artikel |
28 |
Small molecules targeting GRP78 mitigate anti-GRP78 autoantibody–mediated tissue factor procoagulant activity in cultured endothelial cells
|
Chen, Jack |
|
|
22 |
11 |
p. 3290-3304 |
artikel |
29 |
Targeted treatments for vascular malformations: current state of the art
|
Seront, Emmanuel |
|
|
22 |
11 |
p. 2961-2975 |
artikel |
30 |
Targeting cargo to an unconventional secretory system within megakaryocytes allows the release of transgenic proteins from platelets
|
Asquith, Nathan L. |
|
|
22 |
11 |
p. 3235-3248 |
artikel |
31 |
The molecular background of quantitative defects of von Willebrand factor
|
Atiq, Ferdows |
|
|
22 |
11 |
p. 3004-3006 |
artikel |
32 |
The use of direct oral anticoagulants in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia
|
Kovac, Mirjana |
|
|
22 |
11 |
p. 3322-3329 |
artikel |
33 |
Universal clinical decision support tool for thromboprophylaxis in hospitalized COVID-19 patients: post hoc analysis of the IMPROVE-DD cluster randomized trial
|
Goldin, Mark |
|
|
22 |
11 |
p. 3172-3182 |
artikel |
34 |
Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study
|
Krahforst, Alexander |
|
|
22 |
11 |
p. 3010-3034 |
artikel |
35 |
Very long–term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis
|
Galanaud, Jean-Philippe |
|
|
22 |
11 |
p. 3148-3160 |
artikel |